The Alzheimer’s Drug Discovery Foundation will be moderating a session, “Beyond Amyloid and Tau: Emerging Solutions,” at the 2022 Clinical Trials on Alzheimer’s Disease (CTAD) conference, which will be held November 29th through December 2nd at the Hilton Union Square in San Francisco, California.
Recent News in Senolytics
-
The Promise of Senolytic TherapiesOct 2, 2023 | Senolytic News
-
AI Unlocks New Frontier in Anti-Aging MedicineAug 24, 2023 | Senolytic News
-
Reversing Aging in Stem CellsJun 29, 2023 | Uncategorized
-
Fighting aging with immune checkpoint blockadeNov 23, 2022 | Senolytic News
-
Senolytic treatment shows promise in DME, wet AMDNov 20, 2022 | Senolytic News
-
Senolytics to Tackle Age-Related PathologiesNov 19, 2022 | Senolytic News